4-(6-acetamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-(6-acetamido-1H-benzimidazol-2-yl)-N-methylbenzamide;4-(6-benzamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;3,4-dichloro-N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]benzamide

C136H134Cl2N24O12 — CID 159421238

IUPAC4-(6-acetamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-(6-acetamido-1H-benzimidazol-2-yl)-N-methylbenzamide;4-(6-benzamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;3,4-dichloro-N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]benzamide
SMILESCC(=O)Nc1ccc2nc(-c3ccc(C(=O)NC4CCCC4)cc3)[nH]c2c1.CNC(=O)c1ccc(-c2nc3ccc(NC(=O)C4CCCC4)cc3[nH]2)cc1.CNC(=O)c1ccc(-c2nc3ccc(NC(C)=O)cc3[nH]2)cc1.O=C(NC1CCCC1)c1ccc(-c2nc3ccc(NC(=O)C4CCCC4)cc3[nH]2)cc1.O=C(Nc1ccc2nc(-c3ccc(C(=O)NC4CCCC4)cc3)[nH]c2c1)c1ccc(Cl)c(Cl)c1.O=C(Nc1ccc2nc(-c3ccc(C(=O)NC4CCCC4)cc3)[nH]c2c1)c1ccccc1
InChIInChI=1S/C26H22Cl2N4O2.C26H24N4O2.C25H28N4O2.2C21H22N4O2.C17H16N4O2/c27-20-11-9-17(13-21(20)28)26(34)30-19-10-12-22-23(14-19)32-24(31-22)15-5-7-16(8-6-15)25(33)29-18-3-1-2-4-18;31-25(18-6-2-1-3-7-18)28-21-14-15-22-23(16-21)30-24(29-22)17-10-12-19(13-11-17)26(32)27-20-8-4-5-9-20;30-24(17-5-1-2-6-17)27-20-13-14-21-22(15-20)29-23(28-21)16-9-11-18(12-10-16)25(31)26-19-7-3-4-8-19;1-22-20(26)15-8-6-13(7-9-15)19-24-17-11-10-16(12-18(17)25-19)23-21(27)14-4-2-3-5-14;1-13(26)22-17-10-11-18-19(12-17)25-20(24-18)14-6-8-15(9-7-14)21(27)23-16-4-2-3-5-16;1-10(22)19-13-7-8-14-15(9-13)21-16(20-14)11-3-5-12(6-4-11)17(23)18-2/h5-14,18H,1-4H2,(H,29,33)(H,30,34)(H,31,32);1-3,6-7,10-16,20H,4-5,8-9H2,(H,27,32)(H,28,31)(H,29,30);9-15,17,19H,1-8H2,(H,26,31)(H,27,30)(H,28,29);6-12,14H,2-5H2,1H3,(H,22,26)(H,23,27)(H,24,25);6-12,16H,2-5H2,1H3,(H,22,26)(H,23,27)(H,24,25);3-9H,1-2H3,(H,18,23)(H,19,22)(H,20,21)
InChIKeyLPUHNVJTPRWYSD-UHFFFAOYSA-N
MW2367.63 g/mol
LogP26.77
Rot. Bonds26

About 4-(6-acetamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-(6-acetamido-1H-benzimidazol-2-yl)-N-methylbenzamide;4-(6-benzamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;3,4-dichloro-N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]benzamide

4-(6-acetamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-(6-acetamido-1H-benzimidazol-2-yl)-N-methylbenzamide;4-(6-benzamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;3,4-dichloro-N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]benzamide (PubChem CID 159421238) has the molecular formula C136H134Cl2N24O12 and a molecular weight of 2367.63 g/mol. Its IUPAC name is 4-(6-acetamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-(6-acetamido-1H-benzimidazol-2-yl)-N-methylbenzamide;4-(6-benzamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;3,4-dichloro-N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]benzamide.

Molecular Properties

Compound Name4-(6-acetamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-(6-acetamido-1H-benzimidazol-2-yl)-N-methylbenzamide;4-(6-benzamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;3,4-dichloro-N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]benzamide
PubChem CID159421238
Molecular FormulaC136H134Cl2N24O12
Molecular Weight2367.63 g/mol
Exact Mass2365.00
IUPAC Name4-(6-acetamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-(6-acetamido-1H-benzimidazol-2-yl)-N-methylbenzamide;4-(6-benzamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;3,4-dichloro-N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]benzamide
SMILESCC(=O)Nc1ccc2nc(-c3ccc(C(=O)NC4CCCC4)cc3)[nH]c2c1.CNC(=O)c1ccc(-c2nc3ccc(NC(=O)C4CCCC4)cc3[nH]2)cc1.CNC(=O)c1ccc(-c2nc3ccc(NC(C)=O)cc3[nH]2)cc1.O=C(NC1CCCC1)c1ccc(-c2nc3ccc(NC(=O)C4CCCC4)cc3[nH]2)cc1.O=C(Nc1ccc2nc(-c3ccc(C(=O)NC4CCCC4)cc3)[nH]c2c1)c1ccc(Cl)c(Cl)c1.O=C(Nc1ccc2nc(-c3ccc(C(=O)NC4CCCC4)cc3)[nH]c2c1)c1ccccc1
InChIInChI=1S/C26H22Cl2N4O2.C26H24N4O2.C25H28N4O2.2C21H22N4O2.C17H16N4O2/c27-20-11-9-17(13-21(20)28)26(34)30-19-10-12-22-23(14-19)32-24(31-22)15-5-7-16(8-6-15)25(33)29-18-3-1-2-4-18;31-25(18-6-2-1-3-7-18)28-21-14-15-22-23(16-21)30-24(29-22)17-10-12-19(13-11-17)26(32)27-20-8-4-5-9-20;30-24(17-5-1-2-6-17)27-20-13-14-21-22(15-20)29-23(28-21)16-9-11-18(12-10-16)25(31)26-19-7-3-4-8-19;1-22-20(26)15-8-6-13(7-9-15)19-24-17-11-10-16(12-18(17)25-19)23-21(27)14-4-2-3-5-14;1-13(26)22-17-10-11-18-19(12-17)25-20(24-18)14-6-8-15(9-7-14)21(27)23-16-4-2-3-5-16;1-10(22)19-13-7-8-14-15(9-13)21-16(20-14)11-3-5-12(6-4-11)17(23)18-2/h5-14,18H,1-4H2,(H,29,33)(H,30,34)(H,31,32);1-3,6-7,10-16,20H,4-5,8-9H2,(H,27,32)(H,28,31)(H,29,30);9-15,17,19H,1-8H2,(H,26,31)(H,27,30)(H,28,29);6-12,14H,2-5H2,1H3,(H,22,26)(H,23,27)(H,24,25);6-12,16H,2-5H2,1H3,(H,22,26)(H,23,27)(H,24,25);3-9H,1-2H3,(H,18,23)(H,19,22)(H,20,21)
InChIKeyLPUHNVJTPRWYSD-UHFFFAOYSA-N
XLogP26.77
TPSA521.28 Ų
H-Bond Donors18
H-Bond Acceptors18
Rotatable Bonds26
Heavy Atoms174
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002367.63
LogP ≤ 526.77
H-Bond Donors ≤ 518
H-Bond Acceptors ≤ 1018

Analyze 4-(6-acetamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-(6-acetamido-1H-benzimidazol-2-yl)-N-methylbenzamide;4-(6-benzamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;3,4-dichloro-N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-(6-acetamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-(6-acetamido-1H-benzimidazol-2-yl)-N-methylbenzamide;4-(6-benzamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;3,4-dichloro-N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]benzamide?
The IUPAC name of 4-(6-acetamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-(6-acetamido-1H-benzimidazol-2-yl)-N-methylbenzamide;4-(6-benzamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;3,4-dichloro-N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]benzamide (CID 159421238) is 4-(6-acetamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-(6-acetamido-1H-benzimidazol-2-yl)-N-methylbenzamide;4-(6-benzamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;3,4-dichloro-N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]benzamide.
What is the SMILES notation for 4-(6-acetamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-(6-acetamido-1H-benzimidazol-2-yl)-N-methylbenzamide;4-(6-benzamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;3,4-dichloro-N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]benzamide?
The canonical SMILES for 4-(6-acetamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-(6-acetamido-1H-benzimidazol-2-yl)-N-methylbenzamide;4-(6-benzamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;3,4-dichloro-N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]benzamide is CC(=O)Nc1ccc2nc(-c3ccc(C(=O)NC4CCCC4)cc3)[nH]c2c1.CNC(=O)c1ccc(-c2nc3ccc(NC(=O)C4CCCC4)cc3[nH]2)cc1.CNC(=O)c1ccc(-c2nc3ccc(NC(C)=O)cc3[nH]2)cc1.O=C(NC1CCCC1)c1ccc(-c2nc3ccc(NC(=O)C4CCCC4)cc3[nH]2)cc1.O=C(Nc1ccc2nc(-c3ccc(C(=O)NC4CCCC4)cc3)[nH]c2c1)c1ccc(Cl)c(Cl)c1.O=C(Nc1ccc2nc(-c3ccc(C(=O)NC4CCCC4)cc3)[nH]c2c1)c1ccccc1.
What is the InChIKey of 4-(6-acetamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-(6-acetamido-1H-benzimidazol-2-yl)-N-methylbenzamide;4-(6-benzamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;3,4-dichloro-N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]benzamide?
The InChIKey is LPUHNVJTPRWYSD-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H22Cl2N4O2.C26H24N4O2.C25H28N4O2.2C21H22N4O2.C17H16N4O2/c27-20-11-9-17(13-21(20)28)26(34)30-19-10-12-22-23(14-19)32-24(31-22)15-5-7-16(8-6-15)25(33)29-18-3-1-2-4-18;31-25(18-6-2-1-3-7-18)28-21-14-15-22-23(16-21)30-24(29-22)17-10-12-19(13-11-17)26(32)27-20-8-4-5-9-20;30-24(17-5-1-2-6-17)27-20-13-14-21-22(15-20)29-23(28-21)16-9-11-18(12-10-16)25(31)26-19-7-3-4-8-19;1-22-20(26)15-8-6-13(7-9-15)19-24-17-11-10-16(12-18(17)25-19)23-21(27)14-4-2-3-5-14;1-13(26)22-17-10-11-18-19(12-17)25-20(24-18)14-6-8-15(9-7-14)21(27)23-16-4-2-3-5-16;1-10(22)19-13-7-8-14-15(9-13)21-16(20-14)11-3-5-12(6-4-11)17(23)18-2/h5-14,18H,1-4H2,(H,29,33)(H,30,34)(H,31,32);1-3,6-7,10-16,20H,4-5,8-9H2,(H,27,32)(H,28,31)(H,29,30);9-15,17,19H,1-8H2,(H,26,31)(H,27,30)(H,28,29);6-12,14H,2-5H2,1H3,(H,22,26)(H,23,27)(H,24,25);6-12,16H,2-5H2,1H3,(H,22,26)(H,23,27)(H,24,25);3-9H,1-2H3,(H,18,23)(H,19,22)(H,20,21).
What are the key properties of 4-(6-acetamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-(6-acetamido-1H-benzimidazol-2-yl)-N-methylbenzamide;4-(6-benzamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;3,4-dichloro-N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]benzamide?
4-(6-acetamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-(6-acetamido-1H-benzimidazol-2-yl)-N-methylbenzamide;4-(6-benzamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;3,4-dichloro-N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]benzamide has a molecular weight of 2367.63 g/mol, XLogP of 26.77, 26 rotatable bonds, 18 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(6-acetamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-(6-acetamido-1H-benzimidazol-2-yl)-N-methylbenzamide;4-(6-benzamido-1H-benzimidazol-2-yl)-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-cyclopentylbenzamide;4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]-N-methylbenzamide;3,4-dichloro-N-[2-[4-(cyclopentylcarbamoyl)phenyl]-3H-benzimidazol-5-yl]benzamide is sourced from PubChem (CID 159421238), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).